© 1998 by European Society of Cardiology
Copyright © 1998, European Society of Cardiology
Patterns of expression in the developing myocardium: towards a morphologically integrated transcriptional model
Department of Anatomy and Embryology, Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ Amsterdam, Netherlands
* Corresponding author. Tel.: +31 (20) 5664928; fax: +31 (20) 6976177; e-mail: a.f.moorman@amc.uva.nl
KEYWORDS Cardiac morphogenesis; Gene expression; Transgenic mice; Transcriptional regulation
 |
1 Introduction |
|---|
 Top 1 Introduction 2 Morphogenesis of the...3 Patterns of gene...4 Patterns of transgene...5 Cardiac function during...6 Transcriptional regulation in...7 PerspectivesReferences |
|---|
The heart is the first embryonic organ to function. Early in development, the heart shows autorhythmycity and peristaltoid contraction waves [1, 2]. Contraction requires the expression of a specific set of proteins that form the contractile apparatus, i.e. the sarcomere. The contraction–relaxation cycle of the sarcomeric apparatus is mediated by changing local concentrations of free calcium. This function is achieved by another set of specific proteins, located in the sarcoplasmic reticulum and in the sarcolemma.
Fascinating questions that are still poorly understood are how the cardiogenic lineage becomes established to form the peristaltoid contracting tube without valves and how this tube becomes transformed into the synchronous-contracting four-chambered heart with unidirectional valves. It is well documented that the expression of the different isoforms of contractile proteins changes considerably during these stages (for a review see [3]). However, a detailed analysis of the changes in the patterns of gene expression in relation to cardiac morphogenesis is lacking. In the present review we try to fill this gap. We have centred our attention on gene products (mRNA and protein) expressed in the working myocardium of mammals and birds. No distinction has been made when mRNA and protein display the same pattern of expression, however we have highlighted those cases where the pattern of expression differs between mRNA and protein. The development and expression pattern of genes of the conduction system of the heart merits an independent review [4](Moorman et al., Circ. Res., in press). Data referring to other experimental models as Drosophila, Xenopus or zebrafish (Danio rerio) are included only if they are helpful for our general understanding. Often only gene expression in the presumptive atria and/or presumptive ventricles is mentioned, whereas understanding the functional significance of the patterns of gene expression requires knowledge of the entire pattern including the inflow tract, atrioventricular canal and outflow tract. In those cases we have included complementary data from our laboratory, if available. The expression patterns of gene products in other tissues as the mesenchymal cells and cardiac neural crest are not covered in this review. Excellent reviews exist on these topics [5–7].
Patterns of expression have been described in three prototypical developmental stages (see for staging [8]): (i) tubular heart (Fig. 1A), Carnegie stage 
9 (Human: embryonic day (E) 20; Mouse: E8; Rat: E10; Chicken: stage 10 (Hamburger and Hamilton (H/H) [9]), (ii) looped, segmented heart (Fig. 1B), Carnegie stage 012 (Human: E28; Mouse: E10.5; Rat: E12; Chicken: stage 18 (H/H)), and (iii) septated, fetal heart (Fig. 1C), Carnegie stage 23 (Human: E60; Mouse: E16; Rat: E17.5; Chicken: stage 38 (H/H)). Table 1 presents the different mRNAs/proteins included in this review and the species in which the expression patterns have been studied. Secondly, we have compiled the recent data on transgene expression during heart development as far as available (see Table 2). The analysis of such patterns of expression and their relationship with the expression of cardiac-muscle specific transcription factors have been summarised in a model of developmentally regulated cardiac gene expression.
|
|
|
|
2 Morphogenesis of the heart |
|---|
|
Top1 Introduction2 Morphogenesis of the...3 Patterns of gene...4 Patterns of transgene...5 Cardiac function during...6 Transcriptional regulation in...7 PerspectivesReferences |
|---|
The heart originates from the splanchnic mesoderm. Two primordia of epithelial cells (precardiac mesoderm or cardiac crescent) are observed at both sides of the anteroposterior axis of the embryo that eventually will fuse in the midline of the body. As the tubular heart is formed, two epithelial layers are observed, the myocardium and the endocardium, which are separated by an acellular matrix, the cardiac jelly (this stage is illustrated in Fig. 1A). This initial layer of myocardium has been dubbed ‘primary myocardium’ [10].
With further development, the heart loops towards the right side. Subsequently the atrial and ventricular segments become recognisable. Five different segments can be distinguished: two fast-contracting segments, the atria and the ventricles, and three slow-contracting segments, the outflow tract, the atrioventricular canal and the inflow tract [10]. The region of the myocardium that is located upstream of the atria has been dubbed inflow tract. Thus, inflow tract refers to the sinus horns in the embryonic heart and, later in development, to those structures derived from it and those newly formed in the venous pole of the heart. At this stage, the ventricles are characterized by a trabeculated morphology (this stage is illustrated in Fig. 1B).
With further development, septation of the atria and the ventricles proceeds, and right and left components can be recognised in the atrial and ventricular segments. At the same time, the ventricles acquire a compact myocardial morphology, starting in the interventricular septum, followed by the left ventricle and subsequently the right ventricle [11]. The latest event concerning septation of the heart occurs in the outflow tract region where two endocardial ridges fuse and each ventricle, right and left, acquires an independent outlet connection (this stage is illustrated in Fig. 1C). At the end of the septation process, part of the outflow tract myocardium disappears and part becomes incorporated into the right ventricular infundibulum [12, 13]. The atrioventricular canal and the inflow tract become incorporated into the atrial cavities.
|
3 Patterns of gene expression |
|---|
|
Top1 Introduction2 Morphogenesis of the...3 Patterns of gene...4 Patterns of transgene...5 Cardiac function during...6 Transcriptional regulation in...7 PerspectivesReferences |
|---|
The differential distribution of those genes whose patterns of expression are documented in the literature are schematically represented in Fig. 2, in three different stages of heart development.
|
3.1 Contractile proteins
3.1.1 Myosin heavy chains (MHCs)
In the mammalian heart, two myosin heavy chain isoforms are expressed during development,
-MHC and β-MHC, each encoded by a single gene [14, 15](see for review [16]). In chicken, at least three different MHC isoforms have been isolated, two of them are expressed in the atrial myocardium [17–20]and the third is mostly restricted to the ventricular myocardium [17, 18, 21].
In the early tubular stages of development, -MHC and β-MHC are co-expressed along the myocardium in mice, rats, chicken and human [3, 17, 22–24]. -MHC is higher in the atria/inflow tract and progressively decreases towards the ventricle/outflow tract region. β-MHC is highest expressed in the outflow tract/ventricle and decreases towards the atria/inflow tract. In rodents, β-MHC protein is almost homogeneously distributed whereas -MHC protein shows a clear gradient of expression [22].
In the looped heart, -MHC becomes restricted to the atria/inflow tract and β-MHC to the ventricles/outflow tract in rodents [3, 23](our own observations). Co-expression of both proteins is observed in the myocardium of the atrioventricular canal [17, 22, 24]. The IVS is depleted of -MHC, whereas the trabeculated ventricular component still shows a moderate intensity of expression. On the other hand, β-MHC expression is mostly restricted to the ventricular/outflow tract compartments with just detectable levels in the atrial myocardium (Fig. 3A). No differences between IVS and trabeculated ventricles can be observed. Interestingly, -MHC expression is transiently maintained in the outflow tract myocardium of chicken, rat and human [11, 17, 24]. -MHC protein remains moderately expressed in the trabeculated component compared to the developing compact myocardial layers (i.e. ventricular free walls) during the late embryonic and fetal stages in rodent, avian and human embryos [11, 17, 22, 24].
|
In the fetal stages,
-MHC is expressed in the atrial myocardium, caval veins, coronary sinus, interatrial septum and in the myocardium of the pulmonary veins. In rat and mouse, the trabeculated part of the developing ventricular myocardium still expresses -MHC protein. β-MHC becomes restricted to the outflow tract and ventricles with no difference between the compact myocardium and the trabeculated component. A more complex situation is observed in chicken where several atrial MHC isoforms, but only one ventricular isoform, are expressed [25, 26]. Current data support the notion that a distinct MHC isoform is mostly confined to the presumptive atrial myocardium [21]whereas another atrial isoform displays a gradient along the cardiac tube [17]. Indeed, two atrial MHC mRNA isoforms have been identified, AMHC1 restricted to the venous pole of the heart [20]and CCSV2 highly expressed in the atrial myocardium and at lower levels in the ventricles [19]. This fact explains the reports on atrial MHC gradients by some authors [17]and atrial-restricted MHC expression by other groups [20, 21, 25, 27].
In summary, the expression of MHCs (mRNA/protein) in mammals shows a prototypical pattern of expression with anteroposterior gradients of gene expression in the tubular stage. With development, MHC isoforms become confined to atrial or ventricular myocardium, and co-expression is found transiently in the flanking segments (i.e. atrioventricular canal myocardium and outflow tract). In the late embryonic and fetal stages, -MHC expression remains higher in the ventricular trabeculations than in the compact myocardium during similar stages of development in different species. This phenotype confers an ‘atrial’-like characteristic to the trabeculations that may result in a faster contraction capacity than the compact myocardium.
3.1.2 Myosin light chains (MLCs)
The myosin light chains are classified in two groups, alkaline (or essential) and regulatory (or phosphorylatable) [28]. Five major alkali MLCs have been cloned in striated muscle. Two fast isoforms (MLC1f and MLC3f) are encoded by a single gene and result from alternative splicing [29–31]. MLC3f mRNA but not MLC1f mRNA is expressed in the developing mouse heart [32, 33]. There are two slow essential MLC isoforms, MLC1v and MLC1sa. MLC1v is expressed in adult slow skeletal and cardiac muscle and is confined principally to the ventricular myocardium. MLC1sa is expressed in adult slow skeletal muscle, smooth muscle and non-muscle tissues [34]. Another isoform, MLC1a (also dubbed embryonic) is expressed in embryonic skeletal muscle and in the heart, mostly restricted to the atrial myocardium [23]. Three isoforms of the regulatory myosin light chain have been reported to be expressed in striated muscle. MLC2a is confined to the atrial myocardium, MLC2v (slow) is expressed in the ventricular myocardium and slow-twitch fibres, and MLC2f is expressed in fast skeletal muscle and transiently in the embryonic heart [35].
During the tubular stages of development, MLC1a, MLC1v and MLC2a mRNAs are expressed along the myocardium of the entire heart tube [3, 23, 36]. MLC2v mRNA has been reported to be exclusively expressed in the presumptive ventricular myocardium in mice [37, 38]and is detectable from E8.5 [37]in mouse and E10 in rat [39]. With development, the different MLC isoforms become confined to a distinct compartment in mouse and rat [3]. In the looped heart MLC1a and MLC2a mRNAs are higher expressed in the atrial/inflow tract area, whereas MLC1v and MLC2v mRNA are predominant in the ventricular/outflow tract regions [3, 23, 40]. Interestingly, the regulatory MLC2a and MLC2v remain expressed, albeit in lower levels, in the slow-conducting, flanking segments, i.e. inflow tract, atrioventricular canal and outflow tract (Fig. 3B) [39, 42]. The expression of MLC2f mRNA is transiently detectable at E9.5 in the mouse, however no description of its expression pattern is reported [35]. MLC3f mRNA is expressed in the atrial/inflow tract, in the ventricles and, at lower levels in the atrioventricular canal, but not in the outflow tract. It also shows higher level of expression in the atrial than in the ventricular myocardium [32]. MLC1a, MLC2a and MLC3f mRNAs show higher expression in the trabeculations than in the IVS and in the compact layer of the ventricular free wall in rodents (Fig. 4A, C; Kelly R, Zammit P, Buckingham M, in preparation). On the other hand, MLC1v and MLC2v mRNAs show a low expression in the trabecular component of the ventricles (Fig. 4B, D) [41].
|
In the fetal stages, MLC1a and MLC2a mRNAs show a similar pattern to that observed for the
-MHC; that is, mostly restricted to the atrial/inflow tract domains, i.e. the atrial myocardium, the interatrial septum, the coronary sinus and the myocardium surrounding the caval and pulmonary veins. MLC2a mRNA remains expressed in the areas derived from the embryonic outflow tract [42]. MLC1v mRNA is expressed exclusively in the ventricles and in the outflow tract-derived myocardium, whereas MLC2v mRNA displays high expression in the ventricular myocardium and low levels of expression in the outflow tract-derived myocardium [42], in the lower rim of the atria and in the interatrial septum [39]. Remarkably, the ‘fast/atrial’-MLC isoforms (MLC1a, MLC2a and MLC3f) are higher expressed in the trabeculations than in the compact myocardium and conversely, the ‘slow/ventricular’-MLC isoforms (MLC1v and MLC2v) are higher expressed in the compact myocardium than in the trabeculations (Fig. 4). In summary, MLC2a shows a gradient in expression in the early stages of heart development, whereas MLC1a and MLC1v are homogeneously expressed. No data are available about the precise topographical distribution of MLC2v and MLC3f mRNAs in the tubular heart. In the looped heart, MLC2a and MLV2v mRNAs become confined preferentially to the atria and ventricles, respectively. Co-expression of both mRNAs is observed in the flanking segments, i.e. inflow tract, atrioventricular canal and outflow tract. Thus, the flanking, ‘primary myocardium’ represents a transcriptional domain that is distinct from the atrial and ventricular transcriptional domains.
3.1.3 Myosin-binding proteins (MyBPs)
Several myosin binding proteins have been described, namely, C-protein, X-protein and M-protein, each type localized in a distinct region of the sarcomere [43, 44]. At present, cardiac MyBP-C mRNA has been found in adult cardiac muscle but not in skeletal muscle. Its developmental pattern of expression is unknown.
3.1.4 Actins
Three different actin isoforms are expressed through the development of the heart, each encoded by a single gene [45–47]. These comprise the two sarcomeric actins, -skeletal actin and -cardiac actin, and the smooth-muscle -actin (-SMA). The expression patterns of the actin isoforms have been studied in detail during early embryogenesis of mouse and chicken [48–50]. Sassoon et al. [49]demonstrated that cardiac -actin is expressed from the cardiogenic plate stage onward in mice. Skeletal -actin was detectable later in development only. Cardiac -actin shows a gradient of expression from the inflow (venous pole, higher expression) to the outflow tract (arterial pole, lower expression). This gradient remained unnoticed in the literature owing to a mislabelling of the outflow tract as the embryonic atrium [49]. Ruzicka and Schwartz [48]have shown that in early stages of avian cardiac development, -SMA is first expressed in the myocardium, followed by the expression of cardiac -actin. Low levels of skeletal -actin were also detected. With further development, -SMA starts to disappear gradually from the myocardium (H/H 12) and is replaced by the sarcomeric isoforms. -SMA remains exclusively expressed in the outflow and inflow tract in chickens [48, 50]. During the late embryonic stages of development, cardiac -actin is expressed in all cardiac compartments, with a slightly lower staining intensity in the trabeculations than in the compact myocardium in rats. No expression of skeletal -actin was observed during these stages (D. Franco, unpublished data).
In the septated heart, a difference in staining intensity in the trabeculations can be observed when compared to the compact myocardium. -SMA protein remains highly expressed in the trabecular component of the embryonic ventricular compartment resembling, at this time-point, the atrial myocardium phenotype in rodents [11]. In man, expression of skeletal -actin mRNA is only observed in the fetal heart (Carnegie stage 23) and is restricted to the papillary muscle whereas cardiac -actin is homogeneous (Fig. 5). [51].
|
In summary, a switch of actin isoform expression is observed during mammalian and avian heart morphogenesis. At comparable developmental stages,
-SMA becomes replaced by cardiac -actin. -SMA is initially expressed in the early myocardial cells and progressively becomes confined to both cardiac poles, when new myocardium is still added to the cardiac tube. In the fetal stages of development, -SMA protein is higher expressed in the trabeculations than in the compact myocardium. A complementary pattern is observed for cardiac -actin mRNA.
3.1.5 Tropomodulin (TM)
Most of the studies of tropomodulin have been devoted to its localization within the sarcomere [52–54]. Its expression pattern in the heart has been confined during early stages of mouse embryogenesis only, where it is homogeneously expressed along the entire tubular heart [55]. At present, data from later developmental stages are insufficient to allow conclusions.
3.1.6 Tropomyosin (Tmyo)
Three different tropomyosins isoforms have been identified, slow and fast and β [56]. Prados et al. [57]have partially described the pattern of expression of -tropomyosin protein in the developing chicken heart. The earliest expression is seen in the atrial and the ventricular myocardium of the segmented heart (Carnegie stage 12, stage 18 H/H). However, these authors do not describe the expression in the flanking segments. In fetal heart, tropomyosin expression increases; the trabeculations show higher expression than the compact myocardium [57]. Further topographical analysis of tropomyosin expression in the early tubular heart and the embryonic stage is desirable to understand the functional significance of tropomyosin expression during cardiac development.
3.1.7 Troponins
The troponin complex is involved in the regulation of striated muscle contraction by their interaction with Ca2+ ions. It consists of three different subunits, troponin C (TnC), troponin I (TnI) and troponin T (TnT) (see for a review [58, 59]).
In striated muscle two different TnC isoforms are expressed, a fast isoform and a slow/cardiac isoform, each encoded by a single gene [60–62]. The slow/cardiac TnC isoform is expressed in the heart [63]but no data are available about the topographic expression. There is no evidence of isoform switching during cardiac development [64]. Cardiac TnC protein is first detected during chicken development in H/H stage 10 along the cardiac tube and remains homogeneously expressed until hatching [65].
In striated muscle three different genes code for the different isoforms, i.e. fast TnI, slow TnI and cardiac TnI. In cardiac muscle all three isoforms are expressed transiently during development [66–68]. In the adult heart only cardiac TnI mRNA is expressed [64, 67]. During early development (Carnegie stage 9, rat E10), no TnI isoforms can be detected in the tubular rat heart. The first expression is observed at E11 along the myocardium [66]. With further development, both atrial/inflow tract and ventricular myocardium show weak expression of slow TnI and high expression of cardiac TnI. Our own studies on the expression of TnI mRNAs show that cardiac TnI mRNA displays a postero-anterior gradient of gene expression, expression decreasing from the venous pole toward the arterial pole of the heart (Fig. 3C). Slow skeletal troponin I mRNA, in contrast, is almost homogeneously expressed in the developing heart with significantly lower expression in the outflow tract myocardium (D. Franco, unpublished data). These data are in agreement with those reported by Gorza et al. [67]with the exception that there is not a sharp boundary between outflow tract and right ventricular myocardium for cardiac TnI expression but just a gradient. Recently, a transient expression of fast TnI mRNA has been reported with a homogeneous distribution in all embryonic cardiac chambers at just detectable levels [68]. As the heart acquires a compact and a trabeculated component in the developing myocardium both, cardiac TnI and slow TnI mRNAs, are higher expressed in the compact myocardium than in the trabeculations (own observations).
Gorza et al. [67]have observed a delay between cardiac TnI mRNA and protein expression. The mRNA was detected in the atrial and the ventricular myocardium from E11 onward, whereas the protein was observed only in atrial myocardium from E18. In contrast, the expression of the slow TnI protein parallels the mRNA expression. These results illustrate that the different TnI isoforms display different programs of gene expression. Furthermore, they illustrate that cardiac TnI is differently regulated at the posttranscriptional level in different regions of the developing myocardium [67]. In contrast with mammals, cardiac TnI mRNA is already detectable in the precardiac mesoderm in Xenopus and its expression remains exclusively in the developing myocardium [69].
In summary, the separate TnI isoforms are expressed differently in the distinct cardiac compartments. The cardiac TnI gene is an example of a gene that is initially expressed in a postero-anterior gradient along the cardiac tube and becomes then homogeneously expressed. It also illustrates that distinct post-transcriptional regulation occurs in the separate cardiac compartments. A different pattern of gene expression is observed at the same developmental stage between different vertebrates which can probably be attributed to a heterochrony in cardiac development.
Three genes code for TnT in striated muscle; fast TnT, slow TnT and cardiac TnT, each of them generating a variety of transcripts by alternative splicing [70–73]. The only TnT gene known to be expressed within the heart is the cardiac TnT. As holds for the TnI isoforms, a shift from the embryonic TnT isoform to the adult isoform goes concomitantly with a regionalisation of the transcripts. Sabry and Dhoot [73]reported that expression of cardiac TnT was higher in the embryonic atrial myocardium than in the ventricular myocardium during rat development. Further studies are required to link the expression of cardiac TnT in relation to cardiac morphology during embryogenesis.
3.1.8 Calponin
Calponin is exclusively found in the adult smooth muscle and it is also expressed in the myocardium during early stages of development [74, 75]. Three different genes have been described based on their nucleotide sequences [76–78]. So far, only calponin-h1 mRNA (also referred to as smooth muscle calponin) has been extensively studied during cardiac development in mouse [74, 75]. The first expression of calponin mRNA is observed at E9.5 with a higher expression in the outflow tract myocardium and lower expression in the rest of the myocardial compartments. Significant expression was also observed in the developing smooth muscle cells of the dorsal aorta. At E14, calponin mRNA has decreased in all cardiac chambers and becomes almost undetectable at E18 [74, 75]. Ya et al. [11]have reported calponin protein expression during cardiac development with a similar spatio-temporal distribution of its mRNA in rats. The fact that calponin mRNA/protein is transiently expressed during early stages of heart development, similar to other smooth muscle proteins, e.g. -SMA, SM22 [11, 79]may reflect the developmental history of cardiac muscle from the visceral mesoderm. Other smooth muscle proteins are not expressed, e.g. smooth muscle-MHC, caldesmon [11, 80], which makes the functional role of an early transient expression of smooth muscle proteins in the developing heart puzzling.
3.1.9 Other sarcomeric proteins
Other sarcomeric proteins, not forming an intrinsic part of the thick and thin filaments, have been identified, such as titin, -actinin and myomesin, although there is little information about their topographical distribution in the developing heart [81, 82]. Different isoforms of titin are expressed in cardiac and skeletal muscle [83]which are likely to be derived from alternative splicing of the same gene [84, 85]. Titin mRNA is already expressed in the cardiac plate mesoderm and remains expressed in both atrial and ventricular myocardium with no apparent regional differences [85]. No data are available about the distribution pattern of myomesin [87]or -actinin [86].
3.2 Calcium handling
3.2.1 Sarcoplasmic reticulum calcium ATPase (SERCA)
In mammals, three different SERCA genes have been identified; SERCA1 is expressed in fast skeletal muscle only [88], SERCA2 gives rise to two different mRNAs by alternative splicing which are expressed in cardiac, slow skeletal muscle and some smooth muscle (SERCA2a), and in smooth muscle and non-muscle cells (SERCA2b) [89, 90]. SERCA3 mRNA is more ubiquitous but a detailed topographical distribution is still lacking [91].
Within the heart two isoforms are known at present to be expressed, SERCA2a and SERCA3 [91]. Their distribution patterns have been investigated during rat cardiac development [91, 92]. The first expression of SERCA2a mRNA is observed as early as the precardiac mesoderm is formed [92]. At the tubular looping stage, SERCA2a mRNA shows a caudocranial gradient of expression, high in the venous pole and lower in the arterial pole. As the heart acquires five different segments, expression of SERCA2a mRNA remains lower in the ventricles than in the atria, with a drop in expression in the flanking segments, inflow tract, outflow tract and in particular in the atrioventricular canal [92]. At E13, the compact myocardium shows higher expression of SERCA2a mRNA than the trabeculations [92]. In the fetal stages a different level of expression remains between the atrial and the ventricular myocardium. The expression pattern of SERCA3 mRNA has not been studied in detail. Expression appears in the tubular heart (Carnegie stage 9, rat E10) and disappears in the septated heart (Carnegie stage 23, rat E17.5) [91].
In conclusion, the calcium pump encoded by the SERCA2a gene shows a postero-anterior gradient of gene expression and displays with further development a segmented pattern of expression. This regionalised distribution of SERCA2a mRNA is in agreement with the functional properties of fast-contracting segments: short contraction duration in the upstream segments and increasing towards the arterial pole. The flanking segments have the longest contraction duration as they function as sphincter to substitute the valves. Differences in the phenotype are also observed within the ventricular segment. Expression is lower in the trabecular portion than in the compact myocardium. A functional interpretation of these differences may be that relaxation starts in the outer compact myocardium, where expression levels are the highest. Further analysis is, however required to assess the functional differences in phenotype between trabeculations and compact myocardium as the calcium pump function is mediated by phospholamban, the action of which depends upon its phosphorylation.
3.2.2 Phospholamban (PLB)
The sarcoplasmic calcium ATPase activity is regulated by PLB. PLB is expressed in cardiac, slow-twitch and smooth muscle but not in fast-twitch muscle tissue [93, 94]. PLB is encoded by a single gene directing the synthesis of the same protein in cardiac and slow-twitch muscle [95, 96]. Binding of PLB to the SERCA2 protein inhibits its activity, whereas phosphorylation of PLB prevents binding to the calcium pump [97, 98].
The spatio-temporal distribution of PLB mRNA expression has been studied during embryonic heart development in rat [92]and chicken [99]. In rats, the first expression of PLB mRNA was detected in the segmented heart (Carnegie stage 12, rat E12). PLB mRNA expression shows a craniocaudal gradient of gene expression opposite to that of SERCA [92]. Similar expression is detectable during embryonic chicken development (Carnegie stage 12, stage 14 H/H) [99]. In the septated heart, the atrial/inflow tract shows lower mRNA expression than the ventricular/outflow tract region. As the trabeculations and compact myocardium start to develop, regional differences are observed, the compact myocardium being more heavily stained that the inner trabeculations [92].
The expression of PLB (and of SERCA, see above) supports the differences in cardiac function, that is fast relaxation in the upstream parts of the heart tube owing to high levels of expression of SERCA2 and low levels of PLB, and long contraction duration downstream owing to slow calcium clearance due to low levels of SERCA2 and high levels of PLB. It also supports the notion of a quicker relaxation of the compact myocardium than in the trabeculations. Nevertheless, although in general transcriptional regulation is the predominant regulatory mechanism, posttranscriptional control has to be taken in account.
3.2.3 Ryanodine receptor (RyR)
The extrusion of calcium from the sarcoplasmic reticulum into the cytosol is mediated by the RyR [100, 101]. At present three different forms of RyR have been identified [101–104]. RyR1 is expressed predominantly in skeletal muscle, RyR2 in cardiac muscle and RyR3 in the brain (see for a recent review [101]). The pattern of expression of the three different RyR isoforms has been studied during rat heart development [105](our own data).
In the tubular heart, the RyR2 mRNA expression is evenly detectable along the embryonic cardiac tube, whereas RyR1 and RyR3 transcripts are not detectable.
In the embryonic heart, as in the previous stage, only RyR2 transcript is detectable in the myocardium [105]. RyR2 mRNA is slightly higher in the atrial and ventricular segments, beautifully demonstrating the development of fast contracting segments of working myocardium.
In the fetal stage, RyR2 is expressed in all myocardiocytes with no clear differences in spatial distribution. The atrial myocardium tends slightly to have a higher expression. At this stage, expression of RyR3 transcripts is observed for the first time in both atrial and ventricular cardiomyocytes. Interestingly, RyR2 mRNA is significantly lower expressed in the trabeculations than in the compact myocardium (Fig. 6A). Both transcripts, RyR2 and RyR3, remain expressed in the myocardium until adulthood. No expression of RyR1 mRNA is observed in any stage of development [105].
|
3.2.4 Sodium–calcium exchanger (NCX)
The exchange of calcium ions through the sarcolemma is mediated by the NCX. Different isoforms of the NCX are expressed in different tissues which are derived from a single gene by alternative splicing [106, 107].
Within the heart, only one spliced variant has been detected at present [107]and its topographical expression has been recently studied during rat development ([107]; our own data). At the tubular stage, NCX mRNA is homogeneously expressed and remains so during further development when the different cardiac segments are formed. Only differences between the trabeculations and the compact myocardium were observed in the embryonic and fetal stage (Carnegie stage 12–23, rat E12–17.5), resembling the expression pattern of the cardiac RyR and SERCA2 mRNAs (Fig. 6B). Thus the NCX seems not to contribute to the segmental differences in calcium clearance. In the late fetal period and the adult rat heart a homogeneous expression is observed along the myocardium.
3.2.5 Sodium–potassium ATPase (NaK-ATPase)
The sodium–potassium ATPase (NaK-ATPase) is a membrane-bound enzyme responsible for the regulation of the electrochemical gradient. Molecular characterization of the NaK-ATPase has identified three -subunits (-1, -2 and -3) and, at present, two β-subunits (β-1 and β-2), in mammals. The tissue-specific distribution of the and β isoforms has been documented by Northern blotting and RNAse protection assay analyses during rat development [108, 109], but only the topographical pattern of gene expression of the -isoforms in mice has been reported [110].
In the tubular stage, -1 transcript is expressed in all embryonic and extraembryonic tissues but with higher intensity in the heart. The -2 transcript is observed also along all embryonic and extraembryonic tissues but at lower levels than the -1 isoform. Both isoforms, -1 and -2, are homogeneously expressed within the myocardium. The -3 transcript is not detectable in most of the embryonic tissue, including the heart, but positive in the neural system.
In the segmented heart, the expression of the -3 transcript is first detectable within the atrial and the ventricular myocardium [110]. No differences in expression have been observed within the distinct cardiac compartments. The expression of -2 isoform is, in this stage, higher than the level of expression of the -3 isoform.
In the fetal heart, expression of -3 increases whereas -2 expression decreases. Interestingly, Herrera et al. [110]have observed that the apical ventricular myocytes display lower expression levels of -1 transcript than the myocardial cells located at the base of the heart, and that -1 mRNA is higher expressed in the trabeculations than in the compact myocardium, whereas -3 mRNA shows a reciprocal expression, high expression in the compact myocardium and low expression in the trabeculations. It is proposed by the authors that this pattern of expression contributes to the coordinated myocardial contraction. This notion can also account for the differences in expression between trabeculations and compact myocardium.
3.3 Impulse conduction
3.3.1 Connexins
Propagation of the impulse in the heart is mediated by intercellular channels that aggregate into gap junctions between cardiomyocytes. These channels are formed by transmembrane proteins called connexins (Cxs). Fourteen different connexins have been identified in mammals (see for a recent review [111]). Among them, Cx40, Cx43 and Cx45 have been shown to be associated with the myocytes of the mammalian heart.
The expression patterns of Cx40 and Cx43 have been studied at the mRNA [112, 113]and protein level in rat [114–116]. Cx40 protein expression has been studied immunohistochemically during mouse heart development as well [112]. Cx45 mRNA has been studied by Northern blot analysis only [112]. The first expression of Cx40 and Cx43 mRNAs is observed in the atria and the ventricles, but not in the flanking segments, i.e. inflow tract, atrioventricular canal and outflow tract in the looped heart in rats. Interestingly, the expression pattern between the trabeculations and the compact myocardium in the fetal stage of development (Carnegie stage 20, rat E16) is different for each Cx. Cx43 mRNA is strongly positive in the outer compact myocardium whereas the trabeculations show a lower staining intensity. On the other hand, Cx40 mRNA shows a higher expression in the trabeculations than in the outer compact myocardium. With further development, Cx40 mRNA disappears first from the right ventricle and later from the left ventricular myocardium, showing a temporal right/left difference in expression [113]. Van Kempen et al. [113]have suggested that the temporally separate disappearance of Cx40 mRNA from the fetal ventricles implies that right and left ventricles mature independently. This notion is in agreement with recent data from transgenic mice carrying distinct regulatory sequences of genes expressed in cardiac muscle (see e.g. [32, 117–119]), which demonstrate different transcriptional specificities in the right and left ventricles.
None of these two Cx mRNAs are detectable in the sinoatrial node, atrioventricular node and proximal parts of the bundle branches during development of the rat heart. In early stages of development, Cx40 protein shows a similar expression pattern as its mRNA. Species-specific differences are observed in the fetal stage where Cx40 protein is expressed predominantly in the atrial myocardium and in the ventricular conduction system in the mouse [112].
Cx43 protein and its mRNA have been detected during rat heart development from E13 (Carnegie stage 14) onward, in both atria and ventricles but not in the inflow tract, atrioventricular canal and outflow tract [116]. Gourdie et al. [115]reported expression of the protein three days earlier (Carnegie stage 9, rat E10) possibly due to the use of fluorescent antibodies which give a higher sensitivity of detection. As soon as the ventricles become trabeculated, a higher Cx43 protein expression is observed in the trabeculations compared with the compact myocardium [115]. In this stage, the subepicardial layer of the ventricles and the interventricular septum, that is, the compact myocardium, do not react with the antibody against Cx43 protein. Thus, the expression of Cx43 is exclusively confined to the trabeculations, whereas the mRNA is not [116]. In the fetal stage the levels of Cx43 protein increase both in the trabeculations and in the interventricular septum and compact ventricular layers. In the venous pole of the heart, the myocardium surrounding the caval veins and the pulmonary veins remains negative as well as the sinoatrial node. In neonates, Cx43 protein becomes equally distributed among the ventricular myocardium and its expression is observed in the caval veins and pulmonary veins but not in the sinoatrial node [113].
Cxs display a segmented pattern of expression matching the differences in function of the distinct segments [10, 92, 120]. A yet unsolved issue is the fact that Cx43 mRNA is highly expressed in the ventricular compact myocardium and at just detectable levels in the trabeculations, whereas Cx43 protein is highly expressed in the trabeculations and is less abundant in the compact myocardium. The distribution of Cx43 protein is compatible with a faster conduction via the trabeculations [120].
3.4 Energy metabolism
3.4.1 Creatine kinases
In mammals and chicken, two different but related cytosolic creatine kinases (CK), called MCK (muscle-specific) and BCK (brain-specific), and one unrelated mitochondrial gene product (named ‘Mi’) are found (for a review see [121–123]).
Both MCK and BCK mRNAs have been studied during embryonic mouse and chicken development by in situ hybridization [124]. The first expression of BCK mRNA is observed in the tubular heart (Carnegie stage 9, mouse E8) whereas MCK mRNA is first observed in the late segmented heart (Carnegie stage 16, mouse E12.5). As MCK becomes expressed in the myocardium, the expression of BCK decreases to undetectable levels in the septated heart [124]. BCK mRNA is homogeneously expressed within the cardiac muscle but MCK mRNA expression starts exclusively in the right ventricle [3]and becomes homogeneously distributed one day later. In rat, such a right–left different patterning is also transiently observed later in development (D. Franco, unpublished data) and becomes homogeneously expressed in the ventricular myocardium in the septated heart (Fig. 6C).
The first expression of MCK protein is observed around the same developmental cardiac stage, the segmented heart (Carnegie stage 14–15), in chicken [126], rat [125]and in man [127]. Regional differences in protein expression were observed among the different species. In chicken, the outflow tract, the ventricular trabeculations, the roof of the atrial cavities and the interventricular septum stain strongly with a polyclonal antibody against MCK. The possibility was considered that this pattern could be related to the conduction system [126]. In rats, MCK protein initially is observed in the outflow tract and the trabecules of the right ventricle (E12–14), and subsequently in the venous valves, interatrial septum and sinoatrial node. At E18 homogeneous expression was observed in the entire myocardium [125]. In man, the compact myocardium displays a weak expression compared to the trabeculations. Regional differences were observed at the venous pole of the heart. Those areas derived from the primitive sinus venosus, e.g. the junction of the vena cava superior and the right atrium, the left aspect of the right venous valve and the proximal part of the left sinus horns were almost negative whereas elsewhere the atrial myocardium was positive.
In essence, the expression of creatine kinase isoforms during development shows a shift in expression from BCK to MCK in different species. Interestingly, in mice and rats a transient regionalisation of the expression to the right ventricle/outflow tract is observed at mRNA and protein level, illustrating that this constitutes a separate transcriptional domain. Heterogeneity was also observed at the venous pole of the heart in different species, suggesting a different origin of the participating components. Further analysis is required to understand the different cues directing expression to each region of the venous pole of the heart.
3.5 Intermediate filaments
3.5.1 Desmin
Desmin is a muscle cytoskeletal protein belonging to the family of the intermediate filament proteins. Desmin is derived from a single gene. No data are available about the spatio-temporal expression of desmin mRNA during embryogenesis [128].
Desmin protein is one of the first muscle-specific proteins detected during embryogenesis and it is expressed before titin, sarcomeric actin and myosin heavy chain [83, 129]. At mouse E8.5, desmin is detected in the cardiac primordia; its expression increases with development [130]. In the developing rat heart, desmin is homogeneously expressed during the tubular stage [11]. As the compact myocardial layer is formed, desmin expression becomes very high in the trabeculations whereas the compact myocardium and the interventricular septum display low expression levels. At fetal stages, desmin starts to disappear from the ventricular myocardium but expression remains high in the ventricular conduction system and in the atrial myocardium [11]. A very similar developmental profile is observed during mouse embryonic and fetal development (J. Ya and D. Franco, unpublished data). The high expression of desmin in the trabeculations versus the compact myocardium confers a ‘primitive’ phenotype to the trabeculations, the functional significance of which is not clear yet.
3.6 Cell–cell and cell–matrix contact molecules
3.6.1 Integrins
Integrins are heterodimer receptor molecules formed by two subunits, and β. At present 16 subunits and 8 β subunits have been described that result in 22 functional molecules (for a review see e.g. [131–134]). Cardiac myocytes express several isoforms of integrins, among which the predominant types are -1, -5, -6 and β-1 [135–142].
-1 integrin is expressed during embryonic chicken development (Carnegie stage 9–16, stages H/H 12–29), however no data are available about its distribution in the developing heart [137]. The expression pattern of -5 integrin has been studied in two different mammalian species, macaque and rat [139, 140]. Pow and Hendrickx [139]reported a transient weak expression of -5 integrin protein in all myocardial cells during the early stages of heart development (tubular stage) in the macaque. In rat, similar levels of expression of -5 integrin are observed in the atrial and ventricular myocardium whereas the outflow tract and atrioventricular canal show a lower staining intensity. Expression is not exclusively restricted to the myocardium as the endocardial lining of the atrioventricular cushions and of the outflow tract cushions is also positive. With further development -5 integrin is higher expressed in the trabeculations than in the compact myocardium [139]. -6 integrin mRNA is expressed homogeneously during the early stages of development. With further development a transmural gradient of expression in the ventricular myocardium is observed at the mRNA level in mice [138]and at the protein level in chicken [141]. In both cases a higher expression is observed in the trabeculations than in the compact myocardium. Hierck et al. [138]have reported that -6 integrin mRNA expression is weak in the interventricular septum (i.e. the first structure with a compact myocardial morphology) in the segmented heart. In the fetal stage, low expression is observed in the ventricular compact layers and no expression in the interventricular septum. The expression of β-1 integrin has been studied during late embryonic/fetal stages in rats. Carver et al. [136]reported that β-1 integrin (protein and mRNA) is more prominent in areas with intense remodelling, such as the trabeculations (E11.5). With further development (E15) a homogeneous expression in the ventricular myocardium is observed. β-1 integrin is not only expressed in the myocardium but also in the mesenchymal cells of the developing valves.
Little insight is yet available into the function of integrins which hinders the interpretation of their role during cardiac morphogenesis. Integrin expression is regionalized within the heart suggesting that they may play an important role in the distinct functioning of each cardiac segment.
3.6.2 Cadherins
Cadherins are a family of cell surface glycoproteins that mediate calcium-dependent cell adhesion. They are located in the adherens junctions where they interact with the actin cytoskeleton. They have a highly conserved cytoplasmic domain that acts as binding domain for cytoplasmic proteins called catenins. Cadherins play an important role in different morphogenetic processes such as gastrulation [143, 144], neurulation [145]and cardiogenesis [146–148]. At present, only N-cadherin (A-CAM) has been reported to be expressed in the myocardium [146, 148–151], in chicken. In the tubular heart, N-cadherin seems to be homogenous expressed throughout the myocardium [144]. No data are available on the expression of N-cadherin in the segmented and fetal heart.
3.7 Cardiac-specific transcription factors
During the last couple of years increasing information has become available regarding transcription factors that play essential roles during heart morphogenesis (see e.g. [152]), such as members of the transcription factor families of the homeobox genes (NK family, see for review [153]), GATA genes (see for review [154]) and MADS genes (MEF-2 and bHLH; see for review [155]). The role of such transcription factors seems highly conserved during evolution, as homologous genes are involved in cardiogenesis of different species ranging from Drosophila [156–158], zebrafish [159, 160], Xenopus [161–164], chicken [165]and mouse [37, 166–174].
3.7.1 Homeobox genes
Several homeobox genes of the NK2 subfamily are expressed within the precardiac mesoderm and, with further development, in the myocardial component of the heart [153]. Nkx2.5 transcript is first observed in the cardiac crescent; in the tubular heart stage, it is homogeneously distributed along the entire heart in both the atrial and ventricular myocardiocytes and remains expressed during fetal and adult stages [242].
Recently, a new member of the NK family has been cloned from chicken embryos (cNkx2.8) which shows a regionalised expression within the myocardium [175, 176]. First expression of cNkx2.8 transcript is observed in the precardiac mesoderm. It is homogeneously distributed in the myocardium at the tubular heart (Carnegie stage 9; mouse E8.5). In the embryonic heart (Carnegie stage 12; mouse E10.5) expression becomes regionalised to the cranial and caudal pole of the heart and its expression extends beyond the myocardium, i.e. in the endoderm. In the cranial pole of the heart cNkx2.8 transcripts extend from the distal outflow tract to the aortic sac and pharyngeal pouches 2 and 3. In the caudal pole of the heart, expression of cNkx2.8 mRNA is observed in the sinus venosus and extends into the septum transversum [175, 176]. In later stages, expression in the myocardium is no longer observed [175, 176].
3.7.2 GATA family
At present three members of the GATA family have been described to be expressed in the myocardium (see for a review [154]). GATA-4 transcript can first be detected in the precardiac mesoderm and is evenly expressed within the myocardial component in later stages, as well as in other embryonic structures [170].
More recently, GATA-5 mRNA has been demonstrated to have a dynamic pattern of expression during mouse embryogenesis. First expression of GATA-5 transcript is observed in the precardiac mesoderm. In the embryonic, segmented heart (Carnegie stage 9; mouse E8.5), GATA-5 is expressed throughout the myocardium with higher expression in the outflow tract and inflow tract regions than in the atrial and ventricular segments. In the septated heart (Carnegie stage 23, mouse E14.5), GATA-5 is no longer observed in the myocardium but remains expressed in the atrial endocardium [177].
The developmental pattern of expression of GATA-6 mRNA mostly follows that observed for GATA-4 mRNA. No differences in expression have been reported within the myocardial component. In the fetal stage, in addition to the expression in the myocardium, GATA-6 mRNA becomes expressed in the developing aorta and the right and left caval veins as well [171].
3.7.3 Myocyte enhancer factor (MEF)-2 family
Three different members (MEF2A, 2C, 2D) of the MEF family are expressed in the developing heart, however no differential expression is observed within the different cardiac compartments [173]. MEF2C can first be detected in the precardiac mesoderm at approximately E7.5 (Carnegie stage 9) in mice. The expression of MEF2A and MEF2D has been observed for the first time one day later within the developing myocardium as well as in a number of other embryonic tissues.
3.7.4 Basic helix–loop–helix (bHLH) family
The bHLH family of transcription factors includes skeletal muscle-specific genes as MyoD, Myf-5, Mrf-4 and myogenin, which play an essential role in skeletal-muscle specific sarcomeric gene expression, but none of them are expressed in the developing myocardium (see for a review [178]).
Recently, two novel bHLH members, now named dHAND and eHAND, were found to be expressed in the developing heart [155, 179, 180]. In chicken, both transcripts are firstly expressed in the precardiac mesoderm. In the tubular heart stage, dHAND and eHAND are evenly expressed within the myocardium [155].
In contrast to the avian condition, the homologous dHAND and eHAND transcripts in mouse show a very dynamic pattern of expression during heart morphogenesis [169, 179–181]. dHAND and eHAND transcripts are firstly observed in the precardial mesoderm, in mice. Both HAND genes are expressed in the early tubular heart (Carnegie stage 9; mouse E8.5) but dHAND shows an anteroposterior gradient of expression whereas eHAND is homogeneously expressed. In the embryonic heart, expression of eHAND is no longer detectable in the presumptive right ventricle. On the other hand, dHAND becomes confined to the presumptive right ventricle and the outflow tract [169, 181]. In the fetal stage, expression of eHAND remains detectable at low levels in the myocardium. dHAND mRNA is not detectable in the fetal stage in the myocardium and its expression becomes confined to neural crest derivates [169, 181].
3.7.5 Other transcription factors
Transcription factors as the serum response factor (SRF), the cardiac ankyrin repeat protein (CARP) and a novel gene named pCMF1, are also involved in cardiac muscle-specific gene expression in vitro [182–184].
The SRF seems to have a homogeneous expression within the myocardium in the tubular stage (Carnegie stage 9, chicken H/H 11). No data are available from later stages of development [185]. CARP expression has been studied during mouse embryogenesis. CARP mRNA is first expressed evenly in the tubular heart (Carnegie stage 9; mouse E8.5) and, with further development (Carnegie stage 12; mouse E10.5), expression decreases in the ventricle but remains higher in the outflow tract and atria. Expression of pCMF1 is firstly observed throughout the myocardium in the fusing cardiac plates (Carnegie stage 9; chicken H/H 9) and remains evenly expressed in the myocardium until the embryonic stage (Carnegie stage 12; chicken (H/H20) [184].
3.8 Miscellanea
Atrial natriuretic factor (ANF) is a peptide hormone with natriuretic and vasoactive properties which is expressed in the developing and adult mammalian heart [186, 187]. ANF is encoded by a single gene [188]. The first expression is observed in the tubular stage (Carnegie stage 9, mouse E8) in the developing mouse heart with a postero-anterior gradient. At E9 a regionalised expression was observed in the looped heart, the presumptive left ventricle and right atrium showed consistently higher expression of ANF mRNA than the presumptive right ventricle [187]. The flanking segments, that is outflow tract, atrioventricular canal and inflow tract do not show ANF expression (D. Franco, unpublished data). With further development, as the heart has become septated (Carnegie stage 16, rat E14), the trabeculated portion of the left ventricle expresses similar amounts of ANF transcript as the atrial myocardium [187]. In contrast, the right and left ventricular free walls (compact myocardium) and the interventricular septum show almost no expression of ANF mRNA (Fig. 6D). At the protein level, no differences in expression are observed between right and left components in the fetal rat ventricles but more stained cells were located in the trabeculations than in the compact layer [189]. Moreover, heterogeneous expression is observed in the venous pole of the heart, structures such as the caval veins, interatrial septum and coronary sinus do not express ANF whereas the atrial myocardium does express it (own observations).
Acetylcholinesterase is a key enzyme in the cholinergic signal transduction pathway encoded by a single gene [190]. Acetylcholinesterase activity has been demonstrated in the developing chicken [191]and rat heart [192, 193], particularly in the developing outflow tract myocardium and the ventricular trabeculations. Its expression declines in the fetal period and disappears shortly after birth. AChE activity was initially hypothesised to constitute an early marker for the development of the conduction system [192]but recently it was shown that AChE did not colocalise with the HNK-1 epitope [193]which has been correlated with the ventricular conduction system [194, 195]. More recently, it has been shown that neither AChE, nor choline-acetyltransferase mRNAs (the enzyme that synthesises acetylcholine) are observed in the developing rat heart [196]leaving up an open question of how AChE activity can be present in the ventricular trabeculations and outflow tract myocardium.
|
4 Patterns of transgene expression |
|---|
|
Top1 Introduction2 Morphogenesis of the...3 Patterns of gene...4 Patterns of transgene...5 Cardiac function during...6 Transcriptional regulation in...7 PerspectivesReferences |
|---|
The objective of studies on the regulatory cues of gene expression is to understand how a certain gene becomes expressed in a distinct spatio-temporal fashion. The identification of cis-acting regulatory DNA elements in flanking sequences of the transcription initiation site by transgenic mice (in vivo assay) has increased our understanding about the molecular mechanisms of gene regulation. Within the heart, certain genes are expressed along the entire cardiac tube (e.g. actins) whereas others become restricted to certain segments (e.g. MHCs and MLCs). In the present section we summarise the current knowledge of the different patterns of expression in transgenic mice. We do not go into the different transcriptional activators (see for a recent review [197]) unless they are relevant for the understanding of the regionalised expression of the transgenes. Table 2 summarizes the genes reviewed and Fig. 7 shows the different expression patterns reported until now, in schematic cartoons of a heart corresponding to approximately mouse E10.5 (Carnegie stage 12).
|
4.1 Contractile proteins
4.1.1 Myosin heavy chains
Subramanian et al. [198]have reported that a sequence of 5.5 kilobases (kb) upstream of the transcription starting site of the
-MHC gene is capable of conferring expression of the chloramphenicol acetyltransferase (CAT) reporter gene to the adult atrial and ventricular myocardium. No differences in expression between atrial and ventricular myocardium have been observed. These data are in agreement with the adult expression pattern of the -MHC endogenous mRNA. Palermo et al. [199]using a 5.5 kb -MHC promoter transgene coupled to the lacZ reporter gene demonstrated that expression of the transgene becomes confined to the atrial myocardium in the segmented heart (Carnegie stage 12; mouse E10.5) and remains expressed in the atrial myocardium as well as it becomes up-regulated in the ventricular myocardium postnatally. Rindt et al. [200]have shown that 5kb of the upstream sequences of the β-MHC gene are able to confer cardiac-specific expression but 2.5 kb or less upstream sequences failed to confer transgene expression in the adult heart. Knotts et al. [201]have shown that the onset of expression of the β-MHC transgene (with 5.5 kb upstream sequence) is similar to the endogenous gene and restricted to the heart. Expression of the transgene is not restricted to the ventricular myocardium at E12 and extended into the atria. Knotts et al. [201]suggest therefore that additional e